LUNG (Pulmonx Corp.) Company Projected Revenue

Brandmark of pulmonx.com (LUNG)

Pulmonx Corporation (LUNG) margin scalability is increasing due to lower manufacturing costs. The company's projected sales volume on GURU.Markets is available for analysis, where the 0.09 mark indicates the current status. Service offerings and software worldwide provide stable income, while FDA approvals create a powerful defensive barrier against new entrants in the emphysema treatment segment.

LUNG - Pulmonx Corporation Company Expected Sales Volume over the range 07/04/2022 - 11/18/2026

Analytical breakdowns and data insights for company Pulmonx Corporation (LUNG)

- current price and projected stock value:
Fundamental company analysis:Pulmonx Corp
Brand item of Pulmonx Corp.

The innovative potential of Pulmonx Corporation (LUNG) relies on the synergy between medical professionals and engineers developing high-tech therapy systems. The metric algorithm aggregates expected cash flows from the sale of these products, transforming sales forecasts into a quantitative equivalent. This indicator measures the future market value of the business through the lens of expected revenue, allowing investors to objectively assess the degree of the asset's undervaluation. Analyzing the organization's sales forecast helps avoid emotional decision-making when determining fair capitalization.

Analysis of competing companies

Company Future Sales Volume DXCM (Dexcom)|Company Future Sales Volume Penumbra PEN|Company Projected Revenue Novanta Photonics NOVT|Haemonetics Corp. (HAE) - Company Expected Sales Volume|Inspire Medical - Projected Sales Volume|Company Expected Sales Volume PROCEPT BioRobotics|CNMD: Projected Sales Volume|Company Revenue Forecast PLSE|INMD (InMode MD) - Projected Sales Volume|Company Future Sales Volume Picard Medical Inc. (PMI)|Projected Sales Volume SRDX|Company Future Sales Volume Senseonics Holdings SENS|Projected Sales Volume NPCE (neuropace.com)|Projected Sales Volume Tactile Systems Technology TCMD|SNWV - Company Projected Revenue|Company Expected Sales Volume Outset Medical Corp|ELMD (Electromed Inc) - Company Future Sales Volume|LENSAR, Inc. - Company Future Revenue|RCEL (AVITA Medical Inc) - Projected Sales Volume|Company Expected Sales Volume profoundmedical.com PROF|Company Projected Revenue Baird Medical (BDMD)|EDAP Medical (EDAP) - Company Sales Forecast|Apyx Medical Corp - Company Future Sales Volume|Projected Sales Volume IceCure Medical, Ltd. ICCM|TELA Bio Inc. - Projected Sales Volume|Company Future Sales CytoSorbents Corporation CTSO|Sensus Healthcare (SRTS) - Company Projected Revenue|Company Expected Revenue ZYXI (Zynex Corp)|Company Projected Revenue electrocore.com|Company Future Sales Volume Vicarious Surgical Inc. (RBOT)|Projected Sales Volume IINN|SeaStar Medical Holding Corp - Company Revenue Forecast|Company Projected Revenue iridex.com IRIX|INBS: Company Revenue Forecast|XAIR: Company Future Sales Volume|profusa.com - Company Projected Revenue Volume|STRATA Skin Sciences (SSKN) - Company Projected Revenue|Company Sales Forecast glucotrack.com GCTK|NAOV (nanovibronix.com) - Projected Sales Volume|Company Expected Sales Volume Venus Concept Corporation VERO|Company Future Sales Volume NUWE (nuwellis.com)|Company Projected Revenue Volume AEMD|Company Projected Revenue asensus.com ASXC|AVGR: Company Revenue Forecast|BioSig Technologies, Inc - Projected Sales Volume|Company Future Revenue CUTR (Cutera, Inc)|KNW: Projected Sales Volume|inarimedical.com - Company Future Revenue|NVRO (Nevro Corp) - Projected Sales Volume|Company Expected Sales Volume ReShape Lifesciences Inc. RSLS|Projected Sales Volume SILK